Investing via convertible bonds gives you the right to convert the invested amount into share certificates of this company in the future

Billboard_goal_3_team_picture_logo Play
Niek Versteegde team 14
Niek Versteegde Uitgeest, NL

GOAL 3 - We All Health

The GOAL 3 monitoring system enables health workers to provide better care with limited resources. Join us to revolutionize healthcare where it is needed most!

$765,140 INVESTED
$291,105 0
Minimum target amount Days left
€750.000 6.00% 5 years
Maximum target amount Interest rate Duration
Small_thumb_niek GOAL 3 - We All Health
The concept

Click here to watch our video!


Every year, more than 3 million children in low- and middle income countries die from conditions that are easily treatable. Affordable treatment, costing less than a dollar, is usually available, but the conditions are recognized too late to be treated effectively.

To detect these critical conditions in time it is essential to monitor vital signs like heart rate and breathing rate continuously. In many low-resource settings (e.g. African settings), this is not possible due to shortage of staff and lack of suitable equipment. Up to 70% of existing monitoring systems are not functioning and there are 10 times less health workers in Africa compared to western settings.

Consequently, the staff monitors the vital signs manually , which is less accurate and time consuming, or is unable to monitor the vital signs at all. This causes delays in diagnosis, increased number of deaths and leads to overburdening of health workers. This is a big shame because the number of deaths can be reduced by 10% for every hour saved.

Image 1: Two major problems occuring in the market resulting is the lower quality of care.

Therefore there is an urgent need for smart monitoring systems that enable health workers to diagnose critical conditions in an early stage and to identify the patients with the highest medical priority. This will save time by bringing the focus to the right patient at the right time.

Image 2: Comparison in diagnosis between Western and African settings for infectious diseases.

At this moment, existing patient monitoring systems are designed for high-resource settings and do not function (well) in low-resource settings due to their complexity in use and maintenance as well as their high costs. These systems break down easily and can’t be maintained. There are affordable monitoring devices but those lack many functionalities needed in the high- and intensive care wards. For example they are meant for short measurements instead of continuous monitoring to detect deteriorations early. There are no monitoring systems with predictive algorithms that support health workers.

We believe that these algorithms will be a game changer in getting an early diagnosis in situations with low numbers of staff with lower training levels.


The system GOAL 3 is developing addresses these challenges, the IMPALA monitoring system (Image below) is developed with and for its users. The most important requirements are robustness and usability.. Our tablet-centered design enables us to develop and integrate software applications and algorithms that support health workers in their work. Through algorithms and decision support we help clinicians to take better decisions around diagnosing and treatment. 


By developing this smart, yet simple monitoring system we will reduce the number of children dying from treatable diseases. In addition, it will reduce the pressure on the health system by reducing the number of admissions and promoting early discharge. Our partners from the Amsterdam Medical Centre have calculated that our solution can save the lives of up to 1 million children per year.

Image 3: Simple representation of the GOAL 3 IMPALA monitoring system

Business model

To ensure the growth and sustainability of GOAL 3 and to make these systems available and sustainable within these settings we need to innovate in the business model. This requires a business model that is tailored to LMIC to guarantee the service, support, maintenance, and installations needed for functioning and continued development of this system. GOAL 3 aims to provide this innovative service for an all-inclusive subscription model that starts at $1 per system per day.

Partnerships and development

Our main partners in the development of the system are the department of paediatric (children) intensive care from the Amsterdam Medical Centre (professor Job van Woensel) and the neonatal (newborns) intensive care department from the Radboud MC Amalia Paediatric hospital (professor Willem de Boode). Together with them we have formed the IMPALA and the IMPALA-NEO consortiums respectively to co-develop this system. World-class research institutes from the Netherlands, the UK, Malawi and Zimbabwe as well as key stakeholders like governmental and non-governmental organisations are represented within these partnerships.

We currently have a functioning prototype monitoring system which can monitor 10 patients at the same time. In the coming 6 months this system will be tested in two pilot studies in Malawi and the Netherlands. In addition we will start the development of the predictive algorithms based on historic data-sets. Following development we expect to launch our first product at the start of 2023.

Mission & vision

GOAL 3 is a social enterprise with a vision of fair and accessible healthcare for everyone. Health workers are the key to achieve that. That is why our mission is to enable and empower health workers at places where it is needed most. To achieve that we are developing the user friendly and algorithm enhanced IMPALA monitoring system that is specifically designed for low resource settings. By supporting health workers in prioritization, monitoring and risk assessment we will prevent children from dying from treatable conditions and we will reduce the pressure on the health system. Our goal is to improve access to care for 100 million people by 2030.

Image 4: Reference from professor J.C.W. van Woensel on GOAL 3

Unique Selling Points

Company USP’s - Why GOAL 3:

  • For health workers, by health workers - GOAL 3 originated out of the need and experiences of health workers, working in LMIC settings. These origins are deeply intertwined in the way products, business models and services are designed. This makes GOAL 3 unique in the field. These values are carried throughout its team.
  • A strong and multidisciplinary team with an entrepreneurial spirit and dedication - within a year the GOAL 3 team has expanded to 10 mission-driven and committed people with a complementary background. All team members are investing significantly in cash and in-kind to make a success out of GOAL 3.
  • Striving for collaboration instead of competition - GOAL 3 has taken a leading role in creating consortia with research institutes, hospitals, and private organizations, to collectively solve the problems around the enormous child mortality. This has resulted in a network of strong and unique partners, funding and talent that share our mission.
  • Focusing on places where it is needed most - The mission of GOAL 3 is to focus its activities on the places where it is needed most. This mission makes GOAL 3 unique and creates an expert role in understanding, designing, developing and collaborating at these places.

    Image 5: The GOAL 3 IMPALA monitoring system in co-development in the Queen Elizabeth Hospital in Malawi. The sensitive pressure (ballistographic) sensor is lying below the soft mat children lie upon during their admission to measure heart rate and breathing rate. Due to these characteristics it is very patient friendly and easy to handle for caregivers and health workers.

Product USP’s - Why the IMPALA monitoring system

  • The system is being designed with (Malawian) hospital technicians to make it robust and reliable in a setting in which currently most of the equipment fails.

  • The user interfaces are co-developed with the users to make the system easy to use and learn and increase productivity.

  • The very sensitive pressure (ballistographic) sensor we use is durable and easy to use and is very suitable for this context. It is put underneath the patient without direct contact and measures breathing rate and heart rate in high quality.

  • The tablet with monitoring software provides an intuitive interface with a central patient overview and enables health workers to monitor 10-20 patients at the same time.

  • It is an integrated system in which all parts work seamless together through a software and data backbone.

  • Our system will have predictive algorithms that support health workers in getting an early diagnosis and making a risk assessment. We are developing these algorithms with world-class research partners from Europe and Africa.

  • Through the tablet additional supportive software applications and algorithms can be added over time by ourselves but also partners. We have contact with several parties who are developing tools like this that are suitable for future integration.

  • GOAL 3 aims to offer a complete solution to the hospitals, supporting with providing education, installation, service and maintenance. This can be done via innovative business models that work via a subscription model, making sure the systems stay up and running.

  • The IMPALA monitoring system will have an intuitive interface that is very easy-to-use and fit for purpose for health workers in African settings.

Image 6: The GOAL 3 IMPALA product USPs compared to high-end and low-cost solutions.

Revenue model

  • Our initial target markets are hospitals in Africa and large non-governmental organizations (NGO) such as MSF, Unicef and Save the Children. There are approximately 5,000 hospitals in Africa that need an estimated 15-60 monitoring devices per hospital.
  • The main customer-segments for our product are financially stable LMIC hospitals, ministries of health from African countries, and non-governmental organizations (NGO) involved in healthcare.
  • GOAL 3 sells its monitoring systems either via direct sales to hospitals with an innovative all-inclusive, monitoring as a service, business model starting $1 per system per day, or via traditional tender processes from consortia of local governments, NGOs and organizations such as the UN and WorldBank. For the latter, payment will be done upfront ensuring GOAL 3 with a more stable cash position.
  • The subscription model ensures a lock-in via close collaborations with the customer, the hospitals, and adds many future possibilities for delivering more services such as electronic patient records and supplying other medical equipment.
  • The traditional tender processes provide big, secure and stable project-based funding containing upfront payments for service and maintenance providing GOAL 3 with the financial stability to scale.

Image 7: Schematic overview of the GOAL 3 revenue model

Niek Versteegde

As a tropical doctor I experienced first hand what it means to make an impact. Unfortunately I have also seen dozens of children die from conditions which could have been treated easily. These experiences drive me every day to make a success of GOAL 3.

Annelot van Halder
Head of HR & Communications (MSc)

During my studies in Organizational Psychology, I developed a fascination for new ways to form teams based on employees’ talents and needs. As Head of People within GOAL 3, an organization that has such an inspiring mission, my professional ambitions meet my personal aspirations to make an impact.

Martin Macharia
Senior full stack developer

My passion for technology started the first time I interacted with a computer. I knew it’s what I wanted to do. Build solutions that help improve or in one way or another, have a positive impact in people’s lives. GOAL 3’s mission and product are inline with my objectives and has provided me another.

Bart Bierling

I started designing the first patiënt monitor for low-resource settings, because I believe there is a need for medical devices designed specifically for that context since the current systems don’t suit their needs. I want to create user-centered systems that help to diagnose patients earlier.

Jelle Schuitemaker

As a young entrepreneur and innovation manager, I am passionate about social-technical innovations that can make a real long-term change in the world and disrupt a market. For me, with GOAL 3, we can make this change towards a world where fair and accessible healthcare is the standard!

Kevin Gerrits

During my 15 years in financial services, my personal urge arose more and more to contribute to society with my acquired knowledge and experience. As my interest in various sustainable development goals has grown strongly during this period, GOAL 3 came at the right time.

Tijs Versteegde
Systems architect (MSc)

While working on purely commercial products has been a fun challenge, visiting Niek in Tanzania some years back, put the idea in my head that I wanted to contribute more to the world. So when he told me about this endeavor he started with Bart, there was no doubt that I'd love to use my experience to do exactly that!

Rachel Loop
Head of Quality (MSc)

As a Biomedical Engineer and Industrial designer, I strive to build a bridge between the work of health-workers, designers and engineers to create innovative health-tech solutions through collaboration in multidisciplinary teams. At GOAL 3 I found a unique path to do exactly what I aspire for a very good societal cause.

Balt Leenman
Business advisor (ing)

During all of my career, I have been working on innovative technology. At this phase of my life, I enjoy sharing my experience with young entrepreneurs. GOAL 3 is a great idea, a paradigm shift for healthcare! I especially appreciate the focus on the least fortunate people. I can leverage my experience and network in East Africa.

Jori Spierings
Graphic design

In 2015 I visited Niek in Tanzania and followed him during his clinical duties. This made me aware about the huge challenges of these settings. Unable to contribute at that time I was happy to join GOAL 3 to help to visually communicate the inspiring mission.

Legal structure

Human development

Marketing & sales channels

Marketing objective

Turnover so far

Projected turnover

Invested so far